The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Open accessAbstract
Peripheral insulin resistance and impaired insulin action are the primary characteristics of type 2 diabetes. The first observable defect in this major disorder occurs in muscle, where glucose disposal in response to insulin is impaired. We have developed a transgenic mouse with a dominant-negative insulin-like growth factor-I receptor (KR-IGF-IR) specifically targeted to the skeletal muscle. Expression of KR-IGF-IR resulted in the formation of hybrid receptors between the mutant and the endogenous IGF-I and insulin receptors, thereby abrogating the normal function of these receptors and leading to insulin resistance. Pancreatic beta-cell dysfunction developed at a relative early age, resulting in diabetes. These mice provide an excellent model to study the molecular mechanisms underlying the development of human type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IGF1 acts primarily on skeletal muscle, where it elicits its insulin-sensitizing effects [228] (Figure 2).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [228]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor
LeRoith, D., Werner, H., Beitner‐Johnson, D., & Roberts, C. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,424
Self-citationNormal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418
Self-citationMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Self-citationBrüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,173
Kulkarni, R., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743
(1997) · Diabetes reviews · Cited by 671
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
Accili, D., Drago, J., Lee, E. J., Johnson, M. D., Cool, M. H., Salvatore, P., Asico, L. D., José, P. A., Taylor, S. I., & Westphal, H. (1996) · Nature Genetics · doi:10.1038/ng0196-106 · Cited by 594
Flagged first, then by citations
1 of the 33 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1016/S1097-2765(00)00010-1 · DOI · Paper page
Cited by
Sorted by citations
PPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,650
Huang, S., & Czech, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,450
Copps, K. D., & White, M. F. (2012) · Diabetologia · doi:10.1007/s00125-012-2644-8 · Cited by 1,017
“The binding of insulin to the insulin receptor (IR), and in muscle tissues to hybrid insulin/ IGF1 receptors (IR/IGF1R) [7], promotes the autophosphorylation of a trio of regulatory loop tyrosine residues, disinhibiting IR tyrosine kinase activity toward IRS [8].”
BackgroundVigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
The many faces of insulin-like peptide signalling in the brain
Fernandez, A. M., & Torres-Alemán, I. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3209 · Cited by 872
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Schiaffino, S., & Mammucari, C. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-4 · Cited by 816
“IGF1 receptor(2) Viable Transient delay of postnatal muscle growth; unaffected overload-induced muscle hypertrophy; impaired muscle regeneration [59-62]”
BackgroundObesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806
Self-citationAyala, J. E., Samuel, V. T., Morton, G. J., Obici, S., Croniger, C. M., Shulman, G. I., Wasserman, D. H., & McGuinness, O. P. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006239 · Cited by 722
Self-citationFROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Biddinger, S. B., & Kahn, C. R. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124723 · Cited by 714
de Álvaro, C., Teruel, T., Hernández, R., & Lorenzo, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312021200 · Cited by 435
Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy
Booth, F. W., Chakravarthy, M. V., Gordon, S. E., & Spangenburg, E. E. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00073.2002 · Cited by 426
Insulin resistance and pancreatic cell failure
Kasuga, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29189 · Cited by 433
Considerations in the Design of Hyperinsulinemic-Euglycemic Clamps in the Conscious Mouse
Ayala, J. E., Bracy, D. P., McGuinness, O. P., & Wasserman, D. H. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0686 · Cited by 406
The proliferating role of insulin and insulin-like growth factors in cancer
Gallagher, E. J., & LeRoith, D. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.06.007 · Cited by 398
Self-citationMolecular and cellular mechanisms of skeletal muscle atrophy: an update
Fanzani, A., Conraads, V. M., Penna, F., & Martinet, W. (2012) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-012-0074-6 · Cited by 386
Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions
Duan, C., & Xu, Q. (2005) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2004.12.022 · Cited by 354
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
Clemmons, D. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2359 · Cited by 340
Frystyk, J. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.06.001 · Cited by 336
FTO: the first gene contributing to common forms of human obesity
Loos, R. J. F., & Bouchard, C. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00481.x · Cited by 321
Hyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0250 · Cited by 344
Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes
Clemmons, D. R. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.017 · Cited by 298
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., Ita, J. R. D., de la Garza, R. G., & Castilla‐Cortázar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 297
Testis determination requires insulin receptor family function in mice
Nef, S., Verma‐Kurvari, S., Merenmies, J. M., Vassalli, J. D., Efstratiadis, A., Accili, D., & Parada, L. F. (2003) · Nature · doi:10.1038/nature02059 · Cited by 292
Oxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A. M., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 283
Self-citationCarro, E., & Torres‐Alemán, I. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.050 · Cited by 262
Insulin Receptor Knockout Mice
Kitamura, T., Kahn, C. R., & Accili, D. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142540 · Cited by 263
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 289
Self-citationSpangenburg, E. E., Roith, D. L., Ward, C. W., & Bodine, S. C. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.141507 · Cited by 259
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252
Mouse models of insulin resistance
Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 251
Mouse Models of Insulin Resistance
Nandi, A. A., KITAMURA, Y., Kahn, C. R., & Accili, D. (2004) · Physiological Reviews · doi:10.1152/physrev.00032.2003 · Cited by 249
Gallagher, E. J., & LeRoith, D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0295-5 · Cited by 241
Self-citationCarvalho, E., Kotani, K., Peroni, O. D., & Kahn, B. B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00116.2005 · Cited by 247
Diabetes, Obesity, and Breast Cancer
Kang, C., LeRoith, D., & Gallagher, E. J. (2018) · Endocrinology · doi:10.1210/en.2018-00574 · Cited by 232
Self-citationThe Key Role of Mitochondrial Function in Health and Disease
San-Millán, I. (2023) · Antioxidants · doi:10.3390/antiox12040782 · Cited by 254
Bayol, S. A., Simbi, B. H., & Stickland, N. C. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.088989 · Cited by 229
Minokoshi, Y., Kahn, C. R., & Kahn, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300019200 · Cited by 224
Role of IGF-I in skeletal muscle mass maintenance
Clemmons, D. R. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.04.002 · Cited by 225
The WNT signalling pathway and diabetes mellitus
Jin, T. (2008) · Diabetologia · doi:10.1007/s00125-008-1084-y · Cited by 211
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity
Clemmons, D. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20660 · Cited by 208
Snail1 is stabilized by O‐GlcNAc modification in hyperglycaemic condition
Park, S., Kim, H. S., Kim, N. H., Ji, S., Cha, S. Y., Kang, J. G., Ota, I., Shimada, K., Konishi, N., Nam, H. W., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.254 · Cited by 210
Insulin Regulates Glucagon-Like Peptide-1 Secretion from the Enteroendocrine L Cell
Lim, G. E., Huang, G. J., Flora, N., LeRoith, D., Rhodes, C. J., & Brubaker, P. L. (2009) · Endocrinology · doi:10.1210/en.2008-0726 · Cited by 200
IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge
Spadaro, O., Camell, C. D., Bosurgi, L., Nguyen, K., Youm, Y., Rothlin, C. V., & Dixit, V. D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.046 · Cited by 201
The Identification of Potential Factors Associated with the Development of Type 2 Diabetes
Lu, H., Yang, Y., Allister, E. M., Wijesekara, N., & Wheeler, M. B. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700478-mcp200 · Cited by 198
Cancer Drug Discovery and Development
Humphrey, J. S., Price, K., Gupta, E., Baxter, A. R. W., Bird, J., Sonnichsen, D. S., & Naglich, J. G. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-325-5_21 · Cited by 195
The Sense of Smell Impacts Metabolic Health and Obesity
Riera, C. E., Tsaousidou, E., Halloran, J., Follett, P., Hahn, O., Pereira, M. M. A., Ruud, L. E., Alber, J., Tharp, K., Anderson, C. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.015 · Cited by 191
Kim, H., Haluzı́k, M., Shyr, Z. A., Yau, D., Joseph, J. W., Fernandez, A. M., Reitman, M. L., Yakar, S., STANNARD, B. S., Héron‐Milhavet, L., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1770 · Cited by 192
Self-citationMinireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
Jin, T., & Liu, L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0135 · Cited by 194
The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis
Da, W., Tao, L., & Zhu, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.675385 · Cited by 185
Role of IGF-I signaling in muscle bone interactions
Bikle, D. D., Tahimic, C. G. T., Chang, W., Wang, Y., Philippou, Α., & Barton, E. R. (2015) · Bone · doi:10.1016/j.bone.2015.04.036 · Cited by 187
Lu, H., Koshkin, V., Allister, E. M., Gyulkhandanyan, A. V., & Wheeler, M. B. (2009) · Diabetes · doi:10.2337/db09-0129 · Cited by 181
Toward a comprehensive neurobiology of IGF‐I
Torres‐Alemán, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20778 · Cited by 177
Laustsen, P. G., Russell, S. J., Cui, L., Entingh-Pearsall, A., Holzenberger, M., Liao, R., & Kahn, C. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01110-06 · Cited by 173
Differential role of insulin/IGF-1 receptor signaling in muscle growth and glucose homeostasis
O’Neill, B. T., Lauritzen, H. P. M. M., Hirshman, M. F., Smyth, G., Goodyear, L. J., & Kahn, C. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.037 · Cited by 171
Delibegović, M., Bence, K. K., Mody, N., Hong, E., Ko, H. J., Kim, J. K., Kahn, B. B., & Neel, B. G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00959-07 · Cited by 173
Self-citationAccili, D. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1633 · Cited by 171
Dominici, F. P., Argentino, D. P., Muñoz, M. C., Miquet, J. G., Sotelo, A. I., & Turyn, D. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.07.001 · Cited by 169
A Review of Rodent Models of Type 2 Diabetic Skeletal Fragility
Fajardo, R. J., Karim, L., Calley, V. I., & Bouxsein, M. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2210 · Cited by 166
Calcineurin signaling and neural control of skeletal muscle fiber type and size
Schiaffino, S., & Serrano, A. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02111-9 · Cited by 160
Signalling through IGF-I and insulin receptors: where is the specificity?
Kim, J. J., & Accili, D. (2002) · Growth Hormone & IGF Research · doi:10.1054/ghir.2002.0265 · Cited by 163
Self-citationYi, F., Sun, J., Lim, G. E., Fantus, I. G., Brubaker, P. L., & Jin, T. (2008) · Endocrinology · doi:10.1210/en.2007-1142 · Cited by 158
Al-Samerria, S., & Radovick, S. (2021) · Cells · doi:10.3390/cells10102664 · Cited by 165
Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes12
Lorenzo, M., Fernández‐Veledo, S., Vila‐Bedmar, R., García‐Guerra, L., de Álvaro, C., & Nieto-Vázquez, I. (2007) · Journal of Animal Science · doi:10.2527/jas.2007-0462 · Cited by 161
Transgenic rescue of insulin receptor–deficient mice
Okamoto, H., Nakae, J., Kitamura, T., Park, B.-C., Dragatsis, I., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421645 · Cited by 151
Kiely, P. A., Sant, A., & O’Connor, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201758200 · Cited by 150
Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women
Rajpathak, S. N., He, M., Sun, Q., Kaplan, R. C., Muzumdar, R. H., Rohan, T. E., Gunter, M. J., Pollak, M., Kim, M., Pessin, J. E., et al. (2012) · Diabetes · doi:10.2337/db11-1488 · Cited by 148
Involvement of insulin-like growth factor-I in the control of glucose homeostasis
Clemmons, D. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.006 · Cited by 144
Nawrocki, A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.003 · Cited by 144
Carro, E., Trejo, J. L., Spuch, C., Bohl, D., Heard, J. M., & Torres‐Alemán, I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.039 · Cited by 139
Fernandez, A. M., Fernandez, S., Carrero, P., Garcia-Garcia, M., & Torres-Aleman, I. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1002-07.2007 · Cited by 124
Role of Insulin-Like Growth Factor Iin Maintaining Normal Glucose Homeostasis
Clemmons, D. R. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080763 · Cited by 132
Fernandez, A. M., Dupont, J., Farrar, R. P., Lee, S., STANNARD, B. S., & Roith, D. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13503 · Cited by 132
Self-citationTwo Tales of Antioxidant Enzymes on β Cells and Diabetes
Lei, X. G., & Vatamaniuk, M. Z. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3416 · Cited by 134
Nigi, L., Grieco, G. E., Ventriglia, G., Brusco, N., Mancarella, F., Formichi, C., Dotta, F., & Sebastiani, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123705 · Cited by 128
On the participation of mTOR in recognition memory
Myskiw, J. D. C., Rossato, J. I., Bevilaqua, L. R., Medina, J. H., Izquierdo, I., & Cammarota, M. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.10.002 · Cited by 122
Okamoto, H., Obici, S., Accili, D., & Rossetti, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23096 · Cited by 121
Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis
Guo, Y., Xie, C., Li, X., Yang, J., Yu, T., Zhang, T., Zhang, T., Saxena, D., Snyder, M. P., Wu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15621 · Cited by 119
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 117
Kineman, R. D., del Río-Moreno, M., & Sarmento‐Cabral, A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0076 · Cited by 119
Strle, K., Broussard, S. R., McCusker, R. H., Shen, W. H., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2004) · Endocrinology · doi:10.1210/en.2003-1749 · Cited by 118
Fernandez, A. M., Dupont, J., Farrar, R. P., Lee, S., STANNARD, B. S., & Roith, D. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213503 · Cited by 111
Self-citationDeficiency of Adrenomedullin Induces Insulin Resistance by Increasing Oxidative Stress
Shimosawa, T., Ogihara, T., Matsui, H., Asano, T., Ando, K., & Fujita, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000066846.46422.2c · Cited by 109
Mitochondrial regulation of β-cell function: Maintaining the momentum for insulin release
Kaufman, B. A., Li, C., & Soleimanpour, S. A. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.01.004 · Cited by 107
The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer
Lann, D. E., & LeRoith, D. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9100-x · Cited by 104
Self-citationOf bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat
Shavlakadze, T., & Grounds, M. D. (2006) · BioEssays · doi:10.1002/bies.20479 · Cited by 104
Ren, J. T., & Anversa, P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.006 · Cited by 100
Leptin Improves Insulin Resistance and Hyperglycemia in a Mouse Model of Type 2 Diabetes
Toyoshima, Y., Gavrilova, O., Yakar, S., Jou, W., Pack, S., Shyr, Z. A., Wheeler, M. B., & LeRoith, D. (2005) · Endocrinology · doi:10.1210/en.2005-0087 · Cited by 108
Self-citationThe signaling landscape of insulin-like growth factor 1
Khan, M. Z., Zugaza, J. L., & Torres‐Alemán, I. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108047 · Cited by 115
A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo
Shavlakadze, T., Chai, R. J., Maley, K., Cozens, G. S., Grounds, G., Winn, N., Rosenthal, N. A., & Grounds, M. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.061119 · Cited by 97
Evolution of the Insulin Receptor Family and Receptor Isoform Expression in Vertebrates
Hernández‐Sánchez, C., Mansilla, A., de Pablo, F., & Zardoya, R. (2008) · Molecular Biology and Evolution · doi:10.1093/molbev/msn036 · Cited by 99
Ferguson, R. D., Novosyadlyy, R., Fierz, Y., Alikhani, N., Sun, H., Yakar, S., & LeRoith, D. (2012) · Breast Cancer Research · doi:10.1186/bcr3089 · Cited by 97
Self-citationIGF signaling defects as causes of growth failure and IUGR
Klammt, J., Pfäffle, R. W., Werner, H., & Kieß, W. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.03.003 · Cited by 98
PPAR-alpha and insulin sensitivity
Haluzík, M., & Haluzı́k, M. (2006) · Physiological Research · doi:10.33549/physiolres.930744 · Cited by 95
IGF1R mutations as cause of SGA
Klammt, J., Kiess, W., & Pfäffle, R. W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.09.012 · Cited by 96
Ezzat, V., Duncan, E. R., Wheatcroft, S. B., & Kearney, M. T. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00709.x · Cited by 91
Kim, H., Barton, E. R., Muja, N., Yakar, S., Pennisi, P. A., & LeRoith, D. (2004) · Endocrinology · doi:10.1210/en.2004-0906 · Cited by 93
Self-citationGLP-1(7-36)-amide and Exendin-4 Stimulate the HPA Axis in Rodents and Humans
Gil‐Lozano, M., Pérez–Tilve, D., Álvarez-Crespo, M., Martís, A., Fernandez, A. M., Catalina, P. F., González-Matías, L. C., & Mallo, F. (2010) · Endocrinology · doi:10.1210/en.2009-0915 · Cited by 91
Galván, V., Logvinova, A. V., Sperandio, S., Ichijo, H., & Bredesen, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211398200 · Cited by 93
Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle
Romanick, M. A., Thompson, L. V., & Brown‐Borg, H. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.011 · Cited by 104
Metadata
- Authors
- Fernández, A. M., Kim, J. K., Yakar, S., Dupont, J., Hernandez-Sanchez, C., Castle, A. L., Filmore, J., Shulman, G. I., & Le Roith, D.
- Affiliations
- National Institutes of Health (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2001-08-01
- Volume
- 15
- Issue
- 15
- Pages
- 1926-1934
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC312754
- OpenAlex
- W2125231550
- Cited by
- 369
- References
- 33
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 8 · 2023: 14 · 2022: 11 · 2021: 18 · 2020: 15 · 2019: 7 · 2018: 7 · 2017: 12 · 2016: 16 · 2015: 25 · 2014: 15 · 2013: 13 · 2012: 19
- Type
- posted content
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- Genes & Development (publishedVersion, other-oa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Ministerio de Educación y Cultura
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080756, R01DK040936)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 2 diabetes, insulin resistance, IGF-1 receptor, insulin receptor, skeletal muscle, dominant negative receptor, hybrid receptors, transgenic mouse model, beta-cell dysfunction, glucose disposal
- MeSH terms
- Insulin Secretion, Aging, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Glucose, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Islets of Langerhans, Liver, Mice, Transgenic, Prediabetic State, Receptor, Insulin, Triglycerides, Glucose Clamp Technique, Mutagenesis, Site-Directed, Receptor, IGF Type 1, Muscle, Skeletal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
